Money, Fiance News, Press Release Distribution
Financial News and Press Release Distribution Services

Submit RSS Feed | About US | Contact Us





Home | Personal Finance News | Submit Press Release
Unlimited Press Release Distribution
Press release distribution service

Money News Media
Bankrate
CNBC
CNNMoney
Finacial Times
FOX Business
Moneynews


Money News Now


USNews
Reuters Money
RSS News Feed
Get your news feed listed here as other news media shown above! Submit RSS News Feed

Personal Finance News Releases

China Cancer Drug Market will reach US$ 30.5 Billion by the end of the year 2025

(MoneyNewsWire.Net, April 14, 2020 ) China Cancer Drugs Market, by Drugs, Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy, Companies (Merck, Celgene, Eli Lilly, Roche & Sino BioPharma)” provides a complete analysis of China Anti-Cancer Drugs Market.

According to Renub Research, China Cancer Drug Market will reach US$ 30.5 Billion by the end of the year 2025. The core factors that will support the market growth are; rising healthcare infrastructure, increasing cancer testing center, increasing prevalence of cancer disease in China, the launch of various effective cancer drugs in the Chinese market.

Growth in demand for targeted drug therapy, increasing per capita income, rising out of pocket expenditure, people awareness regarding the risk of various cancer, technology advancement are some other factors driving the demand for cancer drugs in China.

Although the negative news is that the mortality rate of cancer patients is growing in China as the cost of a cancer drug is quite high, and there are many side effects of these cancer drugs. Moreover, due to a change in food habits & lifestyle, the aging population, tobacco smoking, the problem is growing.

In terms of mortality, cancer is the second-largest disease in the world. As China is the most populous country in the world, the risk and prevalence rate is increasing at a rapid pace. Per capita income of China are rising since long period of time, people prefer urbanization and western-style food habits. Due to increasing urbanization, the number of smokers rises leads to an increase in the risk of cancer. Being the most significant emerging economies expanding the number of cancer drug products in China will further boost the market in the coming future. Targeted drug therapy is most prevalent in China because of lower side effects.

Request a free Brochure copy of the report: https://www.renub.com/request-sample-page.php?gturl=china-cancer-drugs-market-p.php

China Cancer Drug Market - By Drug Type

In this section of the report, the market is divided into six parts; Monoclonal Antibiotics, Targeted Drugs, Hormonal Drugs, Cytotoxic Drugs,TCM, and Others. The class of cytotoxic drugs is further classified into three parts: antimetabolites, alkaloids of plants, and alkylating agents. Currently, targeted drugs have more ability to kill malignant cells, and they are quite successful due to higher success rates and effectiveness.

Market by Cancer Type

In this study, we have conducted an in-depth market analysis by cancer types; Lung, Stomach, Breast, Esophageal, Liver, & Others. Lung cancer constitutes the largest market share because of the high prevalence rate and the increasing smoker population in China.

Market by Therapy

Targeted drug therapy is growing significantly in China because of its higher effectiveness and success rate than other therapies, according to Renub Research Analysis. In this research, we have assessed a multi-dimensional approach to study each and every cancer therapy that constitutes numerous variables such as core factors supporting market growth, opportunities assessment by each therapy, various challenges that occurred in cancer therapy, etc.

Key Players Analysis

In this section of the report, we have done a complete analysis of top key players. The topmost key players are; Merck, Celgene, Eli Lilly, Roche, and Sino BioPharma. The report includes business overview, historical revenue analysis & forecast, the strategy of the company, and recent development, etc.

China Cancer Drug Market@ https://renubresearch.wixsite.com/report/post/china-cancer-drug-market

Key Topics Covered :

1. Introduction
2. Research Methodology

3. Executive Summary
4. China Cancer Drugs Market


5. Market Share – China Anti-Cancer Drugs

5.1 By Drugs
5.2 By Cancer
5.3 By Therapy


6. Drugs – China Cancer Market

6.1 Cytotoxic Drugs
6.2 Targeted Drugs
6.3 Monoclonal Antibiotics
6.4 Hormonal Drugs
6.5 Traditional Chinese Medicine (TCM)
6.6 Others


7. Cancer Type – Market

7.1 Lung Cancer
7.2 Stomach Cancer
7.3 Breast Cancer
7.4 Esophageal Cancer
7.5 Liver Cancer
7.6 Others


8. Therapy – China Cancer Market

8.1 Chemotherapy
8.2 Targeted Therapy
8.3 Hormonal Therapy
8.4 Others


9. Company Analysis

9.1 Merck
9.2 Celgene
9.3 Eli Lilly
9.4 Roche
9.5 Sino BioPharma


10. Growth Drivers

10.1 Growing Awareness towards Cancer Diagnosis and Treatment
10.2 Increasing Use of Targeted Therapy
10.3 Increasing Research and Development Activities
10.4 Cutting Import Duties on Cancer Drugs


11. Challenges

11.1 High Cost of Cancer Drugs
11.2 Major Side Effects of Cancer Treatment


If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.

Diabetes Drug Market@ https://www.renub.com/diabetes-drug-market-p.php

Epilepsy Drugs Market@ https://www.renub.com/epilepsy-drugs-market-p.php


About Us:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.


Contact Us

Renub Research
Phone: +1-678-302-0700
Email: info@renub.com
Website: www.renub.com
Follow us on LinkedIn: www.linkedin.com/company/renub-research

Renub Research

Rajat Gupta

Market Research, Bus

rajat.gupta@renub.com

Source: EmailWire.Com


Personal Finance News
  • Auto
  • CDs
  • College
  • Credit Cards
  • Insurance
  • Mortgage
  • Mutual Funds
  • Retirement
  • Savings
  • Taxes

  • Money RSS Marketpalce

    Free Finance Magazines Downloads
    Get free publications including magazines, white papers on finance, investments.
    Submit RSS news feed on Finance, Investment.
    Have your feed on news, products or services displayed under this marketpalce. The feed also displayed on a full page and updated daily.



    Money NewsWire is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

    For unlimited press release distribution for $99 per month or $999 per year, call (281) 645-4086 or start posting your press releases online at EmailWire.com.
    Copyright 2009 GroupWeb Media LLC

    GroupWeb Media Network
    AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
    | InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
    Money-NewsWire.Net ™ - Newswire and Press Release service of GroupWeb Media LLC